New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland.
about
Legal highs: staying on top of the flood of novel psychoactive substancesThe toxicology of bath salts: a review of synthetic cathinonesValidation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry.Psychostimulants and movement disorders.Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry.Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV)."Bath salts" and "plant food" products: the experience of one regional US poison center.Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature.Khat and synthetic cathinones: a review.The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.Oral fluid drug analysis in the age of new psychoactive substances.Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases.Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature.Differentiation of cyclic tertiary amine cathinone derivatives by product ion electron ionization mass spectrometry.Multi-organ dysfunction due to bath salts: are we aware of this entity?The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland.Analysis of MDPV in blood--determination and interpretation.Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry.GC-MS, MS/MS and GC-IR Analysis of a Series of Methylenedioxyphenyl-Aminoketones: Precursors, Ring Regioisomers and Side-Chain Homologs of 3,4-Methylenedioxypyrovalerone.Intended and unintended use of cathinone mixtures.Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population.Prevalence of new psychoactive substances in Victorian fatally-injured drivers
P2860
Q26799231-E4DA3088-F6E4-4D32-9C7F-858459292DDAQ28253719-5973E1B6-5741-4960-BF87-6C2DA922A1E5Q33934379-8D9CB2E5-3891-4F45-B05C-68B689C0F829Q34115248-DEA27754-E5F0-4FE7-B108-48036D684E2CQ35489276-CE69836A-7EC6-4724-8FE1-B3B52AF2CA2FQ35536635-955BA6FF-7972-4089-B587-83F7CEC42807Q35917163-D1ED6683-B6FE-489F-98DF-BD2D3686900EQ36441681-FA7B57B7-6116-443B-BBB2-8C880C429290Q36548946-FEC0A917-EAF0-46C8-A970-38BFB984A70BQ36621870-2DFFC23B-E2A6-4645-BFED-A02A988D7F1BQ37226966-0BBDC126-1CB8-4D4B-8C9C-59D8748FFDEDQ38119006-7F1EE0B8-6BAF-4793-9F87-EE4BE47A1C9DQ38169542-B39426D1-80BF-4F17-8347-FF1108E26EE3Q38669049-C643C947-DE0E-4409-8007-95873217DEC3Q38768825-7F3A2FCC-BE7A-4220-BD78-0484EEE5D909Q38850097-B1A1BD54-8400-4E3E-A84D-48EB61EFC228Q38978095-598BE156-3262-4CF3-B341-982AFB0A5BDDQ39409276-680E5D78-6CC0-49BC-989B-58405DDE0969Q40006791-40F32DA2-6741-465F-B992-26E21CB31D6CQ40073484-00A64B2A-1A6E-4DF8-BF3A-F0C6DC1F53F9Q41126358-5FCC1816-ABCA-4B3C-9AD2-97DEF3A000CBQ44006688-79998F0F-3CAF-471E-A81E-868043A8C780Q45219952-FC68D328-D589-423E-9E78-6883BA2941C8Q46478793-0219469D-19DA-4ECD-A2DF-9E3325CD4DC9Q48211628-4EB10E09-85FE-446E-AEC7-5FB7C2551CD5Q48235317-5FAA5BA9-F34F-42DB-9438-F8B22E1AF718Q57986540-A9B4F000-DBEE-46B0-9148-26EA2FEC4E03
P2860
New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@en
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@nl
type
label
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@en
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@nl
prefLabel
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@en
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@nl
P2093
P1476
New designer drug of abuse: 3, ...... pprehended drivers in Finland.
@en
P2093
Janne Rintatalo
Lars Wilhelm
Olaf Schwarz
P304
P356
10.1016/J.FORSCIINT.2011.03.015
P577
2011-04-07T00:00:00Z